High expression of METTL3 enables CRCs to recruit MDSCs by catalyzing m6A-BHLHE41 to enhance the secretion of CXCL1, thus contributing to T cell growth inhibition and CRC development [142]. The gene discussed is METTL3; the disease is colorectal carcinoma.